
Immune-modulating peptide for resilience.
Thymosin Alpha-1 is a peptide originally isolated from the thymus gland with decades of research in immune modulation and chronic infection support.
Modulates T-cell maturation, dendritic cell function, and innate immune signaling — restoring balance in both under- and over-active immune responses.
Typical research protocol: 1–1.5 mg subcutaneously, 2–3× weekly.
For laboratory and research use only. Not intended for human consumption, diagnosis, treatment, cure, or prevention of any disease. All protocols are reference summaries provided for educational purposes — always consult a qualified healthcare professional.